Wellcome Y9C 100 (Retrovir 100 mg)
Generic Name: zidovudine
Pill imprint Wellcome Y9C 100 has been identified as Retrovir 100 mg.
Retrovir is used in the treatment of reduction of perinatal transmission of hiv; occupational exposure; nonoccupational exposure; hiv infection and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Retrovir 100 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- Wellcome Y9C 100
- 100 mg
- Prescription only
- Drug Class:
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- ViiV Healthcare Company
More about Retrovir (zidovudine)
- Retrovir capsules
- Retrovir syrup
- Retrovir injection
- Retrovir (Advanced Reading)
- Retrovir Intravenous (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.